ARMC5 somatic mutations have been detected in hyperplastic adrenocortical nodules of PBMAH patients in addition to the germline mutations, supporting a ‘two-hit’ model for ARMC5 as a tumor suppressor gene [15]. This evidence concerns the gene ARMC5 and neoplasm.